Patient-centered outcomes

CMS Includes the Patient Activation Measure in its Merit-Based Incentive Payment System Starting in 2024

Retrieved on: 
Friday, December 1, 2023
Health, Practice Management, Health Technology, Other Health, Health Insurance, Managed Care, General Health, Patient-centered outcomes, ANA, National Kidney Foundation, NKF, ASN, Organization, National Alliance, White, AHIP, Elective surgery, Kidney disease, ACC, American Society of Nephrology, American Academy, American Diabetes Association, Patient, American Occupational Therapy Association, PAM, University, American Nurses Association, American Academy of Neurology, CMS, Patient Activation Measure, AAOS, Doctor of Public Health, NAMI, Doctor of Philosophy, Medicare, Society, AAN, Mental disorder, MVP Arena, AOTA, Human, Nursing, MIPS, Phreesia

The Patient Activation Measure (PAM) measures a patient’s knowledge, skills and confidence to self-manage their health.

Key Points: 
  • The Patient Activation Measure (PAM) measures a patient’s knowledge, skills and confidence to self-manage their health.
  • Activated patients feel comfortable advocating for themselves and asking for support from their care team to manage their own health.
  • “It’s incredibly gratifying to see CMS include the Patient Activation Measure Performance Measure in its program as a high priority outcome measure.
  • “As a practice that uses the Patient Activation Measure and participates in MIPS, we're incredibly excited to see that PAM will be a MIPS measure going forward.

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

Retrieved on: 
Thursday, November 9, 2023
Science, FDA, Policy, Human, OPEN, Health, ISPOR, Research, HTA, EMA, Master of Science, Patient-centered outcomes, Meta-analysis, Management, Medical device, EU

London, UK – November 9, 2023 – OPEN Health , a preeminent global provider of consulting , HEOR and market access , patient engagement , and scientific and creative communications services, will be presenting innovative research at the upcoming ISPOR Europe conference in Copenhagen, Denmark.

Key Points: 
  • London, UK – November 9, 2023 – OPEN Health , a preeminent global provider of consulting , HEOR and market access , patient engagement , and scientific and creative communications services, will be presenting innovative research at the upcoming ISPOR Europe conference in Copenhagen, Denmark.
  • Key themes of OPEN Health’s research presented this year are patient preference, advanced modeling methodologies, and HTA policy changes.
  • Dr. Elisabeth Fenwick, Chief Scientific Officer at OPEN Health, said: “I am extremely proud to see the research we do at OPEN Health being presented by our scientific experts at the ISPOR EU conference in Copenhagen.
  • To learn more about our presence at ISPOR Europe, visit our website or meet the OPEN Health team at booth #C2-012 in Copenhagen.

OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office

Retrieved on: 
Monday, July 24, 2023
Meta-analysis, Chief scientific officer, The New England Journal of Medicine, Partnership, Data analysis, Health, OPEN, Research, Hout, CEAC, Science, Acquisition, Publication, Master of Science, Patient-centered outcomes, Management

London, UK, July 24, 2023 (GLOBE NEWSWIRE) -- OPEN Health, a global provider of consultancy , HEOR and market access , and scientific communications services, today announced a new team of experts will lead its HEOR & Market Access Scientific Office.

Key Points: 
  • London, UK, July 24, 2023 (GLOBE NEWSWIRE) -- OPEN Health, a global provider of consultancy , HEOR and market access , and scientific communications services, today announced a new team of experts will lead its HEOR & Market Access Scientific Office.
  • Our scientific experts are here to support the HEOR and market access team with their amazing research developing innovative solutions.” Elisabeth commented.
  • The Scientific Office is made up of experts who bring unique skillsets from across OPEN Health’s HEOR & market access service areas.
  • Craig Bennison, MSc, Executive Director and Global Innovation Lead for OPEN Health HEOR & Market Access, will also join the team and will focus specifically on innovation.

Edifecs Presenting, Sponsoring WEDI 2022 National Conference

Retrieved on: 
Monday, October 24, 2022
Data Management, Health, Technology, Health Technology, Health Insurance, Software, News, Health, Medicaid, Data exchange, Conference, Patient-centered outcomes, Electronic data interchange, B2B, No, Privacy, HHS, Twitter, Health equity, Technology, Center, Industry, Health care in the United States, Medicare, Workgroup, Centers for Medicare & Medicaid Services, National Conference, WEDI, FHIR, Workgroup for Electronic Data Interchange, Washington College of Law, Solution, Compliance, Pharmaceutical industry

Edifecs, Inc. , a global health information technology solutions company, is participating in multiple sessions at the Workgroup for Electronic Data Interchange (WEDI) 2022 National Conference , October 25-27 at American University Washington College of Law.

Key Points: 
  • Edifecs, Inc. , a global health information technology solutions company, is participating in multiple sessions at the Workgroup for Electronic Data Interchange (WEDI) 2022 National Conference , October 25-27 at American University Washington College of Law.
  • Edifecs is sponsoring an educational session on automated, real-time prior authorization for payers and providers.
  • The WEDI National Conference educates attendees on the best practices and emerging trends coming out of the healthcare IT industry.
  • For updates on the latest news and announcements at the conference, please follow @Edifecs on Twitter.

Endpoint Outcomes is Now Lumanity

Retrieved on: 
Monday, September 26, 2022
Vietnamese Professionals Society, International Society for Quality of Life Studies, FDA, Center, Center of excellence, Quality, Acquisition, Degenerative disease, Partnership, Patient, Dermatology, International Society of Sculptors, Painters and Gravers, Life, Human, Neurology, HTA, Research, Conference, Endpoint, Patient-centered outcomes, Medical imaging, Pharmaceutical industry, Bob Luman

New York, NY, September 26, 2022 Lumanity today announced that its recent acquisition , Endpoint Outcomes (Endpoint), a company specializing in harnessing the voice of patients to document the impact of treatments on health-related quality of life, has adopted the Lumanity brand creating an integrated, global team of health economics and outcomes research (HEOR) experts.

Key Points: 
  • New York, NY, September 26, 2022 Lumanity today announced that its recent acquisition , Endpoint Outcomes (Endpoint), a company specializing in harnessing the voice of patients to document the impact of treatments on health-related quality of life, has adopted the Lumanity brand creating an integrated, global team of health economics and outcomes research (HEOR) experts.
  • Endpoint provides health outcomes research expertise, adding to the existing strength of Lumanity in HEOR and expanding its global reach by adding a strong presence in the U.S.
  • The Lumanity HEOR team now consists of over 200 research scientists, patient recruitment specialists, modelers, statisticians, and psychometricians in North America, Europe, and Asia.
  • HEOR is an area of strategic focus for Lumanity, and with the addition of the Endpoint team, we are able to continue to broaden our geographic reach across the U.S. and expand our patient-centered outcomes capabilities across Europe to address both HTA and payer needs globally, said Nick Sullivan, Global President, HEOR at Lumanity.

National Quality Initiatives Amplify Health Systems’ Focus on Effective Glycemic Management as Glytec Fortifies Industry Leadership Position

Retrieved on: 
Tuesday, March 15, 2022
Technology, Nursing, Medical Devices, Hospitals, Diabetes, Software, Practice Management, Managed Care, Health, Data Management, Patient-centered outcomes, Baptist Health, Center, Mortality, Roche, Spartanburg Regional Healthcare System, Solution, HITRUST, FACP, Bellin Health, Disease, Vidant Health, Patient, Medicare, Partnership, Hospital, Uncertainty, FDA, Organization, Nursing, Hyperglycemia, COVID-19, Patient safety, Hypoglycemia, Diagnosis, Premier, Inc., CCRN, Insulin, RN, Population, Glucommander, Nebraska Medicine, HIPAA, Bed, Industry, Centers for Medicare & Medicaid Services, Contract, Blood, MDEA, Workflow, E-GMS, Medicine, CMS, LinkedIn, Diabetes, Glucose, Medical device, MD

As organizations place a growing emphasis on patient safety and payments shift to a more value-based model, hospitals and health systems are steadily increasing their focus on ensuring efficient glycemic management.

Key Points: 
  • As organizations place a growing emphasis on patient safety and payments shift to a more value-based model, hospitals and health systems are steadily increasing their focus on ensuring efficient glycemic management.
  • The CMS national quality initiatives have indicated that poor glycemic management has become too pervasive to ignore and hospitals must evolve.
  • Visit Booth #4135 to learn more about Glytec and the impact that insulin management software can have on health systems.
  • Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care.

LexisNexis Risk Solutions Hires National Interoperability Leader Kelly Hoover Thompson to Lead New Government Health Team

Retrieved on: 
Tuesday, March 8, 2022
Government, Industry, Volunteering, Private sector, RELX, Internet Technical Committee, University, Health policy, Risk, Public health, Health, POLST, Association, LexisNexis Risk Solutions, University of Pittsburgh Medical Center, Board, Policy, Efficiency, Commonwealth, CDC, Patient-centered outcomes, Patient, Technology, Solution, Knowledge, Insurance, CEO, LSE, Center, Pharmaceutical industry, YWCA

WASHINGTON, March 8, 2022 /PRNewswire/ -- LexisNexis Risk Solutions today announced it has hired Kelly Hoover Thompson, a national healthcare executive, to lead the new Government Health Team.

Key Points: 
  • WASHINGTON, March 8, 2022 /PRNewswire/ -- LexisNexis Risk Solutions today announced it has hired Kelly Hoover Thompson, a national healthcare executive, to lead the new Government Health Team.
  • Thompson is ideal for the role, drawing on her federal and state government service and decades of healthcare leadership.
  • Thompson will work to build out the Government Health Team at LexisNexis Risk Solutions where she will partner with government leaders across federal, state, and local governments.
  • LexisNexis Risk Solutions continues to invest in our government health business by attracting stellar talent, like Kelly Thompson, with deep subject matter expertise and industry-leading experience.

Butterfly Network Introduces Butterfly Blueprint and World's First FDA-Cleared AI Guidance & Interpretation Software to Support the Practical Application of Ultrasound Information

Retrieved on: 
Monday, February 28, 2022
Health, FDA, Technology, Other Health, Software, General Health, Hardware, Blueprint, Center, Security (finance), COVID-19, NTAP, Butterfly network, University of Rochester Medical Center, Private Securities Litigation Reform Act, Â, Health, Partnership, Growth, HIMSS, U.S. Securities and Exchange Commission, PACS, Licensed practical nurse, Multimedia, CEO, New, Medicare, Patient-centered outcomes, Value, Auscultation, Efficiency, Diagnosis, United Kingdom, Patient, CMS, Network, Software, Apple, Exhibition, Mark (given name), University, URMC, Centers for Medicare & Medicaid Services, Android, NYSE, Tablet, Conference, Marketing, EMR, Technology, Caption, Hospital, Medical imaging, Butterfly

View the full release here: https://www.businesswire.com/news/home/20220228005235/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220228005235/en/
    Leveraging Butterflys unique combination of a whole-body handheld ultrasound device, software, and services, Blueprint brings hospitals and health systems a complete ultrasound solution.
  • By integrating into health systems clinical and administrative systems and workflows, Blueprint delivers a clinical assessment tool at scale.
  • Butterfly Blueprint is complemented with a rich set of optional software and services including Caption Healths AI-guided software.
  • By integrating Caption AI with Butterfly iQ+, were expanding diagnostic toolkits for hospitals, health systems, and wherever a patient needs care.

Health Tech Innovator, Medsien Launches First On The Market Pain Management Remote Therapeutic Monitoring (RTM) Solution

Retrieved on: 
Friday, February 18, 2022
Medicare, Patient, Patient satisfaction, Health, CMS, Pain management, Solution, SAN, Efficiency, RPM, Goal, Patient-centered outcomes, Center, Centers for Medicare & Medicaid Services, RTM, CCM, Physician, Multimedia, Medicine, Program, Health status of Asian Americans, San Francisco Bay Area, Industry, Health insurance, Medical device, Online shopping

SAN FRANCISCO, Feb. 18, 2022 /PRNewswire/ -- Health tech innovator, Medsien launches new RTM program, adding to their successful suite of remote patient monitoring services.

Key Points: 
  • SAN FRANCISCO, Feb. 18, 2022 /PRNewswire/ -- Health tech innovator, Medsien launches new RTM program, adding to their successful suite of remote patient monitoring services.
  • The Centers for Medicare and Medicaid Services (CMS) added RTM service reimbursement for 2022, and the team at Medsien responded with a unique Remote Pain Management RTM program for pain management providers.
  • The first of it's kind - Medsien has launched their new Remote Pain Management program specifically for pain management providers.
  • Medsien RTM solutions now allow pain management specialists to benefit from their highly sophisticated remote patient management programs.

Sirnaomics to Present at TIDES Europe 2021

Retrieved on: 
Tuesday, November 16, 2021
Health, Safety, Cancer, Sirna, RNA interference, RNA, Patient-centered outcomes, Cholangiocarcinoma, Squamous cell skin cancer, Behzad Razavi, PNP, Hepatocellular carcinoma, Primary sclerosing cholangitis, Company, Therapy, US, Clinical trial, Patient, IND, Adult, Pharmaceutical industry

and SUZHOU BIOBAY, China, Nov. 16, 2021 /PRNewswire/ -- Sirnaomics, Inc. , a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announcedthat it will be presenting positive results from a Phase 2a clinical study of the company's lead drug candidate, STP705, for treatment of squamous cell skin cancer in situ(nonmelanoma skin cancer) at the 2021 TIDES Europe event.

Key Points: 
  • and SUZHOU BIOBAY, China, Nov. 16, 2021 /PRNewswire/ -- Sirnaomics, Inc. , a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announcedthat it will be presenting positive results from a Phase 2a clinical study of the company's lead drug candidate, STP705, for treatment of squamous cell skin cancer in situ(nonmelanoma skin cancer) at the 2021 TIDES Europe event.
  • The hybrid conference is taking place digitally and in person at the Sheraton Brussels Airport Hotel in Belgium from November 15-17, 2021.
  • Sirnaomics, Inc., a leading privately held biopharmaceutical company for discovery and development of RNAi therapeutics, is aDelawarecorporation headquartered inGaithersburg, Maryland, with subsidiaries in Suzhou andGuangzhou, China.
  • Sirnaomics has developed a strong portfolio of intellectual property with an enriched product pipeline.